Gastrointest Endosc. 2023 May 5:S0016-5107(23)02505-1. doi: 10.1016/j.gie.2023.04.2091. Online ahead of print.
ABSTRACT
BACKGROUND AND AIMS: Endoscopic ultrasound (EUS)-guided interventions currently serve as first-line treatment for symptomatic pancreatic fluid collections (PFCs) but require high-level expertise and multidisciplinary care. Hospital caseload has not been fully examined in relation to clinical outcomes of patients with endoscopically managed PFCs.
METHODS: Using the Diagnosis Procedure Combination database, a Japanese nationwide inpatient database, we identified 4,053 patients receiving EUS-guided treatment of PFCs at 486 hospitals in 2010-2020 and examined an association of hospital volume (average annual number of cases at a hospital) with in-hospital mortality. Associations with bleeding, length of stay, and total costs were examined as secondary analyses. Multivariable logistic regression analysis was conducted with adjustment for potential confounders.
RESULTS: The hospital volume was inversely associated with the risk of in-hospital mortality (Ptrend < .001). The adjusted odds ratio for in-hospital mortality comparing the extreme quintiles of hospital volume was 0.17 (95% confidence interval, 0.09-0.33). A restricted cubic spline analysis yielded no statistically significant evidence on the nonlinear relationship (Pnonlinearity = .19). The types of stents (plastic vs. lumen-apposing metal stent) appeared to have no effect modification on the volume-mortality relationship (Pinteraction = .58). Higher hospital volume was also associated with lower risk of bleeding, shorter length of stay, and lower medical costs of inpatient care.
CONCLUSIONS: Higher hospital volume was associated with a lower risk of in-hospital mortality of patients receiving EUS-guided treatment of PFCs. A further investigation is warranted to justify the volume-based selective referral of the patients.
PMID:37150410 | DOI:10.1016/j.gie.2023.04.2091